Abstract:Objective. Many studies have identified causal and promotive roles of oxidative stress (OxS) and oxidative damage caused by OxS in the occurrence and progression of cancer. Many biomarkers in the blood circulation of patients may change correspondingly with the development of tumors. This study is aimed at investigating the correlation between OxS and serum trace element (TE) levels of patients with different types of cancer. Methods. 1143 different types of cancer patients and 178 healthy controls from Mar. 2018 to Aug. 2020 in Mianyang Central Hospital were involved in this study. Their levels of OxS parameters (including total oxidant status (TOS), total antioxidant status (TAS), and oxidant stress index (OSI)) and the concentrations of serum TEs (including Cu, Zn, Fe, and Se) were determined. Results. Compared with healthy controls, all types of cancer patients had higher TOS level (all P adj < 0.001 ) and OSI level ( z = 6.228 ~ 9.909 , all P adj < 0.001 ) and lower TAS level (all P adj < 0.001 ). Compared with healthy controls, the changes of four TE levels in serum were different in different types of cancer patients, among which Cu increased in all groups, but there was no statistical difference in gastric and brain cancer; Se decreased in all groups, but there was no statistical difference in gastric, colorectal, esophageal, and other cancer; Zn was significantly decreased in breast cancer patients ( P adj < 0.001 ); there was no statistical difference in the change of Fe in liver, kidney, and other cancer. Spearman correlation showed that the change of Cu concentration was most closely related to the three OxS parameters and was strongly correlated in the observed several types of tumors ( r s > 0.6 ). Multinomial logistic regression showed that the risks of different tumors are related to the level change of multiple TEs and OxS parameters ( OR TOS = 1.19 ~ 2.82 , OR OSI = 2.56 ~ 4.70 , OR TAS = 0.20 ~ 0.46 , OR Cu = 0.73 ~ 1.44 , OR Zn = 0.81 ~ 0.91 , OR Fe = 0.68 ~ 1.18 , and OR Se = 0.22 ~ 0.45 , all P < 0.006 ). Conclusions. The OxS exists in the occurrence and development of cancer, which may be related to the changes of certain trace elements. In order to evaluate OxS correctly, it is necessary to detect TAS and TOS and at the same time, their ratio OSI should be detected. Assessment of markers representing the overall level of OxS and TEs may guarantee improved the monitoring of disease occurrence and development risk in cancer patients.

Associations between serum soluble transferrin receptor and the prevalence of cancers

Increased Serum Soluble Transferrin Receptor Levels Were Associated with High Prevalence of Cardiovascular Diseases: Insights from the National Health and Nutrition Examination Survey 2017–2018

Association between soluble transferrin receptor and systolic hypertension in adults: National Health and Nutrition Examination Survey (2007-2010 and 2015-2018)

Soluble transferrin receptor can predict all-cause mortality regardless of anaemia and iron storage status

Genetically predicted iron status was associated with the risk of prostate cancer

Ferritin and Serum Iron in a Causal Relationship with Estrogen Receptor-Negative Breast Cancer: a Two-Sample Mendelian Randomization Study

Role of iron biomarkers and iron intakes in lung cancer risk: A systematic review and meta-analysis

The Potential Clinical Significance of the Serum Iron and Ferritin Status in Lung Cancer Patients

Association between serum iron status and primary liver cancer risk: a Mendelian randomization analysis

Association of iron status with all-cause and cause-specific mortality in individuals with diabetes

Association Between Dietary Iron Levels and All-Cause and Cancer-Cause Mortality: a Prospective Cohort Study

Iron status correlates strongly to Insulin Resistance among U.S. adults: A nationwide population-base study

Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease

Can Serum Ferritin Serve As a Biomarker for the Prognosis of Gynecological Malignant Tumors? A Retrospective Cohort Study.

The Association Between the Levels of Serum Ferritin and Sex Hormones in a Large Scale of Chinese Male Population

Transferrin receptor 1 in cancer: a new sight for cancer therapy

The Relationship between Serum Trace Elements and Oxidative Stress of Patients with Different Types of Cancer

Association Between Serum Ferritin, Incident Primary Liver Cancer, and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case-Control Study

Supplemental Tables 1 - 3, Figure 1 from High Serum Iron Is Associated with Increased Cancer Risk

Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017-2018) and a controlled animal study

Association of iron metabolism markers, socioeconomic and lifestyle factors with endometriosis: A cross-sectional study